Evidence map›Paper›PMID 23609195›Full record

ArticleMedical oncology (Northwood, London, England)2013

Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion.

Maolan Li, Jun Shen, Xiangsong Wu, Bingtai Zhang, Rui Zhang, Hao Weng, Qian Ding, Zhujun Tan, Guofeng Gao, Jiasheng Mu and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. HRP-3 protects the hepatoma cells from glucose deprivation-induced apoptosis.International journal of clinical and experimental pathology · 2015
    Article
  15. Article
  16. Article
  17. Article
  18. Downregulated expression of metastasis associated in colon cancer 1 (MACC1) reduces gallbladder cancer cell proliferation and invasion.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  19. Article
  20. Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Maolan LiDepartment of General Surgery, Xinhua hospital, School of Medicine, Shanghai Jiaotong University, Room 615, NO.8 Building, 1665 kongjiang road, Shanghai 200092, People's Republic of China.
Jun Shen
Xiangsong Wu
Bingtai Zhang
Rui Zhang
Hao Weng
Qian Ding
Zhujun Tan
Guofeng Gao
Jiasheng Mu
Jiahua Yang
Yijun Shu
Runfa Bao
Qichen Ding
Wenguang Wu
Yang Cao
Yingbin Liu
XinHua Hospital · CNInner Mongolia Medical University · CNSecond Hospital of Shanxi Medical University · CNShanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatoma-derived growth factor (HDGF), a heparin-binding growth factor, has a wide range of biological functions, including mitogenic activity and vascular development. Recent studies demonstrated that HDGF also acted as an oncogene with aberrantly increased activity in multiple human cancers; however, little is known about the biological function of HDGF in gallbladder cancer (GBC). In this study, we focused on the clinical significance and biological functions of HDGF in GBC and found that Nuclear HDGF protein overexpression was frequently detected in GBC tissues. Patients with nuclear HDGF-positive tumors had worse overall survival than patients with HDGF-negative tumors. Furthermore, treatment of GBC lines with HDGF-targeting siRNA oligonucleotides (HDGF-siRNA) significantly reduced the proliferation of GBC-SD and SGC-996 cell lines and diminished both anchorage-independent growth on soft agar and cell migration. These data indicate that HDGF acts as a putative oncogene in GBC and could be a novel diagnostic and therapeutic target for GBC.

Indexed as

Cell Growth ProcessesCell Line, TumorCell NucleusChi-Square DistributionDown-RegulationFemaleGallbladder NeoplasmsHumansImmunohistochemistryIntercellular Signaling Peptides and ProteinsKaplan-Meier EstimateMaleMiddle AgedMultivariate AnalysisNeoplasm InvasivenessRNA Interferencehepatoma-derived growth factorIntercellular Signaling Peptides and Proteins

Identifiers

PMID23609195
OpenAlexW2013658149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.